Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-006794-32Phase 3Active
Phase 3, randomised trial of amoxicillin in erysipelas (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Clinical non-inferiority of 6-day oral amoxicillin vs 14-day standard regimen, Duration of fever and 1 more. Started May 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-006794-32.